Patchy Chorioretinal Atrophy Changes at the Posterior Pole After Ranibizumab for Myopic Choroidal Neovascularization | Zendy

Mariacristina Parravano | Zendy; Fabio Scarinci | Zendy; Marta Gilardi | Zendy; Lea Querques | Zendy; Monica Varano | Zendy; Francesco Oddone | Zendy; Francesco Bandello | Zendy; Giuseppe Querques | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Patchy Chorioretinal Atrophy Changes at the Posterior Pole After Ranibizumab for Myopic Choroidal Neovascularization

Author(s) -

Mariacristina Parravano,

Fabio Scarinci,

Marta Gilardi,

Lea Querques,

Monica Varano,

Francesco Oddone,

Francesco Bandello,

Giuseppe Querques

Publication year - 2017

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.17-22633

Subject(s) - ranibizumab , dioptre , medicine , ophthalmology , atrophy , refractive error , fundus (uterus) , choroidal neovascularization , posterior pole , posterior segment of eyeball , retinal , bevacizumab , surgery , visual acuity , chemotherapy

To investigate the potential role of ranibizumab treatment on the development or enlargement of chorioretinal atrophy (CRA) at the posterior pole in eyes with myopic choroidal neovascularization (mCNV).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research